×
For best experience we recommend to activate Javascript in your browser.
SFRS17A antibody (AA 53-157)
The Mouse Monoclonal anti-SFRS17A antibody (Clone 2G8) (ABIN2198139) specifically detects SFRS17A in WB, ELISA, IHC and IF.
The antibody is reactive with Human samples.
Catalog No. ABIN2198139
$905.21
Plus shipping costs $50.00
Delivery in 11 to 16 Business Days
Quick Overview for SFRS17A antibody (AA 53-157) (ABIN2198139)
Target
See all SFRS17A (AKAP17A) Antibodies
SFRS17A (AKAP17A)
(A Kinase (PRKA) Anchor Protein 17A (AKAP17A))
Reactivity
All reactivities for SFRS17A antibodies
Human
Host
All hosts for SFRS17A antibodies
Mouse
Clonality
All clonalities for SFRS17A antibodies
Monoclonal
Conjugate
All conjugates for SFRS17A antibodies
This SFRS17A antibody is un-conjugated
Application
All applications for SFRS17A antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
Clone
2G8
Product Details anti-SFRS17A Antibody
(hide)
Binding Specificity
All epitopes for SFRS17A antibodies
AA 53-157
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
AKAP17A (A-kinase Anchor Protein 17A, AKAP-17A, 721P, B-lymphocyte Antigen, CCDC133, CXYorf3, DXYS155E, Protein Kinase A-anchoring Protein 17A, PRKA17A, Protein XE7, RP13-297E16.1, Splicing Factor, Arginine/serine-rich 17A, SFRS17A, XE7, XE7Y)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Partial recombinant corresponding to aa53-157 from RP13-297E16.1 (NP_005079) with GST tag. MW of the GST tag alone is 26kD.
Isotype
IgG2b kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2.
Storage
-20 °C
Storage Comment
-20°C
Target Details for SFRS17A
(hide)
Target
SFRS17A (AKAP17A)
(A Kinase (PRKA) Anchor Protein 17A (AKAP17A))
Alternative Name
AKAP17A
NCBI Accession
NM_005088 , NP_005079
Recently viewed
(hide)
Chat with us , powered by LiveChat